Philip Mazzara
General Counsel at Astera Labs, Inc. (ALAB)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $13.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 44103,299 held (−0%) | $352.10 | $15K | -2.8% |
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 82103,217 held (−0%) | $351.24 | $29K | -2.6% |
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 156103,061 held (−0%) | $349.19 | $54K | -2.0% |
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 81102,980 held (−0%) | $348.05 | $28K | -1.7% |
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 269102,711 held (−0%) | $347.02 | $93K | -1.4% |
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 199102,512 held (−0%) | $346.13 | $69K | -1.1% |
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 1,310101,202 held (−1%) | $344.99 | $452K | -0.8% |
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 287100,915 held (−0%) | $343.94 | $99K | -0.5% |
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 415100,500 held (−0%) | $342.95 | $142K | -0.2% |
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 125100,375 held (−0%) | $341.71 | $43K | +0.1% |
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 205100,170 held (−0%) | $340.58 | $70K | +0.5% |
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 50499,666 held (−1%) | $339.74 | $171K | +0.7% |
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 61099,056 held (−1%) | $338.58 | $207K | +1.1% |
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 79798,259 held (−1%) | $337.76 | $269K | +1.3% |
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 22798,032 held (−0%) | $336.65 | $76K | +1.7% |
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 13697,896 held (−0%) | $335.42 | $46K | +2.0% |
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 54097,356 held (−1%) | $334.23 | $180K | +2.4% |
| Aug 19SEC | ALABAstera Labs, Inc. | Sell | 81496,542 held (−1%) | $333.64 | $272K | +2.6% |
| May 26SEC | ALABAstera Labs, Inc. | Sell | 796103,343 held (−1%) | $291.03 | $232K | +17.6% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 9,204109,011 held (−8%) | $235.36 | $2.2M | +45.4% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 990108,021 held (−1%) | $235.41 | $233K | +45.4% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 116107,905 held (−0%) | $233.19 | $27K | +46.8% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 99107,806 held (−0%) | $232.81 | $23K | +47.0% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 387107,419 held (−0%) | $231.31 | $90K | +47.9% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 186107,233 held (−0%) | $230.28 | $43K | +48.6% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 55107,178 held (−0%) | $229.54 | $13K | +49.1% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 275106,903 held (−0%) | $226.71 | $62K | +50.9% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 90106,813 held (−0%) | $225.76 | $20K | +51.6% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 35106,778 held (−0%) | $225.01 | $8K | +52.1% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 245106,533 held (−0%) | $223.75 | $55K | +52.9% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 189106,344 held (−0%) | $222.20 | $42K | +54.0% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 170106,174 held (−0%) | $221.01 | $38K | +54.8% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 274105,900 held (−0%) | $220.20 | $60K | +55.4% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 356105,544 held (−0%) | $218.87 | $78K | +56.4% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 364105,180 held (−0%) | $218.06 | $79K | +56.9% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 646104,534 held (−1%) | $216.97 | $140K | +57.7% |
| May 20SEC | ALABAstera Labs, Inc. | Sell | 395104,139 held (−0%) | $216.31 | $85K | +58.2% |
| Apr 3SEC | ALABAstera Labs, Inc. | Sell Plan | 3,100124,984 held (−2%) | $106.34 | $330K | +221.8% |
| Apr 3SEC | ALABAstera Labs, Inc. | Sell Plan | 1,985122,999 held (−2%) | $107.54 | $213K | +218.2% |
| Apr 3SEC | ALABAstera Labs, Inc. | Sell Plan | 3,415119,584 held (−3%) | $108.40 | $370K | +215.7% |
| Apr 3SEC | ALABAstera Labs, Inc. | Sell Plan | 1,000118,584 held (−1%) | $109.16 | $109K | +213.5% |
| Apr 3SEC | ALABAstera Labs, Inc. | Sell Plan | 500118,084 held (−0%) | $110.35 | $55K | +210.1% |
| Mar 4SEC | ALABAstera Labs, Inc. | Sell Plan | 1,200136,884 held (−1%) | $113.85 | $137K | +200.6% |
| Mar 4SEC | ALABAstera Labs, Inc. | Sell Plan | 677136,207 held (−0%) | $114.81 | $78K | +198.1% |
| Mar 4SEC | ALABAstera Labs, Inc. | Sell Plan | 750135,457 held (−1%) | $115.84 | $87K | +195.4% |
| Mar 4SEC | ALABAstera Labs, Inc. | Sell Plan | 1,205134,252 held (−1%) | $116.85 | $141K | +192.9% |
| Mar 4SEC | ALABAstera Labs, Inc. | Sell Plan | 3,200131,052 held (−2%) | $117.92 | $377K | +190.2% |
| Mar 4SEC | ALABAstera Labs, Inc. | Sell Plan | 1,202129,850 held (−1%) | $118.89 | $143K | +187.8% |
| Mar 4SEC | ALABAstera Labs, Inc. | Sell Plan | 1,566128,284 held (−1%) | $120.23 | $188K | +184.6% |
| Mar 4SEC | ALABAstera Labs, Inc. | Sell Plan | 200128,084 held (−0%) | $120.98 | $24K | +182.9% |
| Feb 19SEC | ALABAstera Labs, Inc. | Sell | 309142,624 held (−0%) | $122.16 | $38K | +180.1% |
| Feb 19SEC | ALABAstera Labs, Inc. | Sell | 1,713140,911 held (−1%) | $122.84 | $210K | +178.6% |
| Feb 19SEC | ALABAstera Labs, Inc. | Sell | 1,435139,476 held (−1%) | $123.93 | $178K | +176.1% |
| Feb 19SEC | ALABAstera Labs, Inc. | Sell | 923138,553 held (−1%) | $124.66 | $115K | +174.5% |
| Feb 19SEC | ALABAstera Labs, Inc. | Sell | 469138,084 held (−0%) | $126.34 | $59K | +170.9% |
| Jan 6SEC | ALABAstera Labs, Inc. | Sell Plan | 100146,940 held (−0%) | $172.65 | $17K | +98.2% |
| Jan 6SEC | ALABAstera Labs, Inc. | Sell Plan | 600146,340 held (−0%) | $174.13 | $104K | +96.5% |
| Jan 6SEC | ALABAstera Labs, Inc. | Sell Plan | 1,100145,240 held (−1%) | $174.98 | $192K | +95.6% |
| Jan 6SEC | ALABAstera Labs, Inc. | Sell Plan | 500144,740 held (−0%) | $176.92 | $88K | +93.4% |
| Jan 6SEC | ALABAstera Labs, Inc. | Sell Plan | 2,304142,436 held (−2%) | $178.31 | $411K | +91.9% |
| Jan 6SEC | ALABAstera Labs, Inc. | Sell Plan | 2,577139,859 held (−2%) | $179.11 | $462K | +91.1% |
| Jan 6SEC | ALABAstera Labs, Inc. | Sell Plan | 1,319138,540 held (−1%) | $179.90 | $237K | +90.2% |
| Jan 6SEC | ALABAstera Labs, Inc. | Sell Plan | 1,300137,240 held (−1%) | $180.98 | $235K | +89.1% |
| Jan 6SEC | ALABAstera Labs, Inc. | Sell Plan | 200137,040 held (−0%) | $182.12 | $36K | +87.9% |
| Nov 19SEC | ALABAstera Labs, Inc. | Sell | 454151,206 held (−0%) | $146.42 | $66K | +133.7% |
| Nov 19SEC | ALABAstera Labs, Inc. | Sell | 1,051150,155 held (−1%) | $145.69 | $153K | +134.9% |
| Nov 19SEC | ALABAstera Labs, Inc. | Sell | 1,801148,354 held (−1%) | $144.53 | $260K | +136.8% |
| Nov 19SEC | ALABAstera Labs, Inc. | Sell | 1,314147,040 held (−1%) | $143.51 | $189K | +138.5% |
| Oct 3SEC | ALABAstera Labs, Inc. | Sell Plan | 700160,873 held (−0%) | $187.21 | $131K | +82.8% |
| Oct 3SEC | ALABAstera Labs, Inc. | Sell Plan | 800160,073 held (−0%) | $188.37 | $151K | +81.7% |
| Oct 3SEC | ALABAstera Labs, Inc. | Sell Plan | 509159,564 held (−0%) | $189.85 | $97K | +80.3% |
| Oct 3SEC | ALABAstera Labs, Inc. | Sell Plan | 1,395158,169 held (−1%) | $190.97 | $266K | +79.2% |
| Oct 3SEC | ALABAstera Labs, Inc. | Sell Plan | 1,000157,169 held (−1%) | $192.21 | $192K | +78.0% |
| Oct 3SEC | ALABAstera Labs, Inc. | Sell Plan | 2,407154,762 held (−2%) | $193.08 | $465K | +77.2% |
| Oct 3SEC | ALABAstera Labs, Inc. | Sell Plan | 2,189152,573 held (−1%) | $194.07 | $425K | +76.3% |
| Oct 3SEC | ALABAstera Labs, Inc. | Sell Plan | 900151,673 held (−1%) | $194.95 | $175K | +75.5% |
| Oct 3SEC | ALABAstera Labs, Inc. | Sell Plan | 100151,573 held (−0%) | $195.66 | $20K | +74.9% |
- Sell
General Counsel Philip Mazzara sold $330K of ALAB at $106.34 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Philip Mazzara sold $213K of ALAB at $107.54 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Philip Mazzara sold $370K of ALAB at $108.40 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Philip Mazzara sold $109K of ALAB at $109.16 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Philip Mazzara sold $55K of ALAB at $110.35 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Philip Mazzara sold $137K of ALAB at $113.85 — pre-scheduled 10b5-1 plan sale.